William Blair & Company
FBT icon

William Blair & Company’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

William Blair & Company’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.2K Sell
275
-43
-14% -$8.89K ﹤0.01% 1687
2025
Q4 		$65.7K Sell
318
-80
-20% -$16K ﹤0.01% 1623
2025
Q3 		$71.4K Buy
398
+73
+22% +$12.4K ﹤0.01% 1600
2025
Q2 		$52.4K Hold
325
– – ﹤0.01% 1604
2025
Q1 		$55.3K Sell
325
-46
-12% -$7.99K ﹤0.01% 1575
2024
Q4 		$61.7K Buy
371
+21
+6% +$3.59K ﹤0.01% 1582
2024
Q3 		$60.2K Sell
350
-50
-13% -$8.28K ﹤0.01% 1606
2024
Q2 		$61.6K Sell
400
-622
-61% -$93.3K ﹤0.01% 1576
2024
Q1 		$157K Sell
1,022
-8
-0.8% -$1.22K ﹤0.01% 1446
2023
Q4 		$163K Buy
1,030
+5
+0.5% +$718 ﹤0.01% 1437
2023
Q3 		$150K Sell
1,025
-16,147
-94% -$2.46M ﹤0.01% 1446
2023
Q2 		$2.63M Buy
17,172
+126
+0.7% +$19.6K 0.01% 605
2023
Q1 		$2.64M Buy
17,046
+5,156
+43% +$810K 0.01% 592
2022
Q4 		$1.83M Buy
11,890
+11,426
+2,463% +$1.69M 0.01% 656
2022
Q3 		$61K Buy
464
+100
+27% +$14K ﹤0.01% 1573
2022
Q2 		$49K Hold
364
– – ﹤0.01% 1633
2022
Q1 		$54K Sell
364
-179
-33% -$26.5K ﹤0.01% 1702
2021
Q4 		$88K Hold
543
– – ﹤0.01% 1711
2021
Q3 		$90K Buy
543
+250
+85% +$42.7K ﹤0.01% 1623
2021
Q2 		$51K Hold
293
– – ﹤0.01% 1692
2021
Q1 		$47K Hold
293
– – ﹤0.01% 1675
2020
Q4 		$49K Sell
293
-29
-9% -$4.71K ﹤0.01% 1632
2020
Q3 		$51K Buy
322
+272
+544% +$44.5K ﹤0.01% 1507
2020
Q2 		$8K Sell
50
-216
-81% -$33.9K ﹤0.01% 1605
2020
Q1 		$35K Hold
266
– – ﹤0.01% 1431
2019
Q4 		$40K Buy
266
+141
+113% +$19.4K ﹤0.01% 1512
2019
Q3 		$15K Hold
125
– – ﹤0.01% 1569
2019
Q2 		$18K Buy
125
+75
+150% +$10.3K ﹤0.01% 1596
2019
Q1 		$8K Hold
50
– – ﹤0.01% 1636
2018
Q4 		$6K Sell
50
-15
-23% -$2.05K ﹤0.01% 1599
2018
Q3 		$10K Buy
65
+15
+30% +$2.27K ﹤0.01% 1568
2018
Q2 		$7K Hold
50
– – ﹤0.01% 1552
2018
Q1 		$7K Buy
+50
New +$6.83K ﹤0.01% 1467
2015
Q1 		– Sell
-4,895
Closed -$499K – 2156
2014
Q4 		$499K Hold
4,895
– – ﹤0.01% 1690
2014
Q3 		$449K Sell
4,895
-2,200
-31% -$191K ﹤0.01% 1724
2014
Q2 		$584K Hold
7,095
– – ﹤0.01% 1621
2014
Q1 		$544K Sell
7,095
-7,250
-51% -$566K ﹤0.01% 1594
2013
Q4 		$992K Hold
14,345
– – ﹤0.01% 1391
2013
Q3 		$929K Hold
14,345
– – ﹤0.01% 1353
2013
Q2 		$835K Buy
+14,345
New +$819K ﹤0.01% 1338

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

William Blair & Company's FBT Position: Q1 2026 in Review

William Blair & Company reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 14% in Q1 2026, selling an estimated $8.89K and leaving 275 shares worth $55.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

William Blair & Company first reported a position in FBT in Q2 2013 and has held it in 40 quarters since. The position peaked at $2.64M in Q1 2023. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • William Blair & Company held 275 shares of First Trust NYSE Arca Biotechnology Index Fund worth $55.2K as of Q1 2026.
  • William Blair & Company sold 43 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $8.89K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #1687 holding.
  • William Blair & Company first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 40 quarters since.
  • William Blair & Company's First Trust NYSE Arca Biotechnology Index Fund position peaked at $2.64M in Q1 2023.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.